Choroidal Neovascularization

These conditions can raise vascular endothelial growth factor (VEGF), a signaling protein that stimulates blood-vessel formation. In this setting, VEGF promotes growth from the choroid toward retinal or subretinal regions. This mechanism explains why these biological stresses can initiate abnormal vascular activity and why VEGF represents an important therapeutic target.

The main damage comes from instability as well as vessel growth. Fragile new vessels may leak fluid or bleed into retinal or subretinal spaces, disrupting tissue function. Subsequent retinal scarring can produce more lasting structural injury. Thus, vision may be impaired through a sequence linking abnormal vascularity, leakage or hemorrhage, and scar formation.

Although neovascular age-related macular degeneration is often associated with this condition, it can also appear with pathologic myopia and other ocular disorders. That distinction matters because choroidal neovascularization is not limited to one disease setting. Recognizing the underlying context helps clinicians interpret the ocular finding alongside the disorder that may contribute to abnormal vessel growth.

Optical coherence tomography (OCT) and fluorescein angiography help clinicians detect and monitor the condition. Their use is especially relevant because the disease can produce fluid leakage, bleeding, and retinal scarring that may affect visual function. These imaging approaches provide clinical information for evaluating retinal changes over time and judging whether vision is being preserved or improved.

Intravitreal anti-VEGF therapy addresses the signaling pathway that drives abnormal vessel formation. By reducing VEGF-related vascular activity, treatment can reduce leakage and may preserve or improve visual function. Its role is therefore not merely diagnostic: it targets a mechanism linked to retinal damage and provides a therapeutic approach for neovascular disease in the eye.

It is particularly important when abnormal vessels threaten vision through leakage, bleeding, or scarring, especially in patients with neovascular age-related macular degeneration. It also has relevance in pathologic myopia and other ocular disorders. Combining recognition of the associated condition with imaging and anti-VEGF treatment connects diagnosis, monitoring, and visual-preservation goals.